| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Troglitazone reduces contraction by inhibition of vascular smooth muscle cell Ca2+ currents and not endothelial nitric oxide production. | Diabetes | 1997 | 0.88 |
| 2 | Insulin-like growth factor I diminishes in vivo and in vitro vascular contractility: role of vascular nitric oxide. | Endocrinology | 1996 | 0.85 |
| 3 | A case of rofecoxib-associated stevens-johnson syndrome with corneal and conjunctival changes. | Cornea | 2004 | 0.75 |